Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

Benzodiazepines and Alzheimer's Risk

Benzodiazepine use is associated with an increased risk of Alzheimer's disease.

Wrist Device Helps Parkinson's Patients

The first wrist-worn device has received FDA approval to assess and monitor symptoms of Parkinson's disease that impact movement.

Blood Type and Cognitive Impairment

Blood group AB and higher factor VIII are associated with increased incidence of cognitive impairment.

Fish Oil for Drug-Resistant Epilepsy

For patients with drug-resistant epilepsy, low-dose fish oil can reduce seizures compared with placebo.

MS Symptoms Worsen with Salt

High sodium intake is associated with increased disease activity in multiple sclerosis (MS).

Breathalyzer to Detect Concussions?

Researchers have proposed a breathalyzer test that could detect chemicals present in athletes’ breath that indicate a brain injury.

Brain Workaround for Alzheimer's

Scientists believe that they may have discovered why some individuals with beta-amyloid buildup retain normal cognitive function.

News

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

A three-minute diagnostic assessment (3D-Confusion Assessment Method [CAM]) has high sensitivity and specificity for identifying delirium, according to a new study.

Fycompa sNDA Under Review for Primary Generalized Tonic-Clonic Seizures

The FDA has accepted for review the Supplemental New Drug Application (sNDA) for Fycompa (perampanel; Eisai) for the treatment of primary generalized tonic-clonic (PGTC) seizures.

Cerebral Microbleeds, Coumarins: Risk Assessment in the General Population

Coumarin use is associated with an increased risk of deep or infratentorial cerebral microbleeds in the general population, according to a new study.

Limb-Girdle Muscular Dystrophies: New Evidence-Based Guidelines

Clinical phenotype, inheritance patterns, and associated manifestations should be used to guide genetic testing for diagnosis of patients with suspected limb-girdle muscular dystrophies (LGMDs), according to evidence-based guidelines.

FEATURES

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

Diagnostic Assessment Accurately IDs Delirium in Three Minutes

A three-minute diagnostic assessment (3D-Confusion Assessment Method [CAM]) has high sensitivity and specificity for identifying delirium, according to a new study.

Fycompa sNDA Under Review for Primary Generalized Tonic-Clonic Seizures

Fycompa sNDA Under Review for Primary Generalized Tonic-Clonic Seizures

The FDA has accepted for review the Supplemental New Drug Application (sNDA) for Fycompa (perampanel; Eisai) for the treatment of primary generalized tonic-clonic (PGTC) seizures.

Cerebral Microbleeds, Coumarins: Risk Assessment in the General Population

Cerebral Microbleeds, Coumarins: Risk Assessment in the General Population

Coumarin use is associated with an increased risk of deep or infratentorial cerebral microbleeds in the general population, according to a new study.

Featured courses from mycme

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular DisordersExternal web site

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...

CME 31.50 Credits

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

Pitfalls in the Diagnosis and Treatment of Migraine HeadacheExternal web site

Migraine and other severe headaches are a common and major public health problem. Faculty presentations ...

CME 1.50 Credits

Sign Up for Free e-newsletters